Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation
Abstract Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Objectives This study assessed the effect of BNP...
Saved in:
| Published in: | Journal of the American College of Cardiology Vol. 68; no. 12; pp. 1297 - 1307 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
20-09-2016
Elsevier Limited Elsevier |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Abstract Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Objectives This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. Methods In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents. Results The cohort had a mean age of 64 ± 15 years, was 66% male, and had a mean ejection fraction 64 ± 9%, mean regurgitant volume 67 ± 31 ml, and low mean Charlson comorbidity index of 1.09 ± 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23). Conclusions In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. |
|---|---|
| AbstractList | Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex.
This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR.
In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents.
The cohort had a mean age of 64 ± 15 years, was 66% male, and had a mean ejection fraction 64 ± 9%, mean regurgitant volume 67 ± 31 ml, and low mean Charlson comorbidity index of 1.09 ± 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23).
In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Objectives This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. Methods In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents. Results The cohort had a mean age of 64 ± 15 years, was 66% male, and had a mean ejection fraction 64 ± 9%, mean regurgitant volume 67 ± 31 ml, and low mean Charlson comorbidity index of 1.09 ± 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23). Conclusions In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. BACKGROUND Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. OBJECTIVES This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. METHODS In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents. RESULTS The cohort had a mean age of 64 +/- 15 years, was 66% male, and had a mean ejection fraction 64 +/- 9%, mean regurgitant volume 67 +/- 31 ml, and low mean Charlson comorbidity index of 1.09 +/- 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23). CONCLUSIONS In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. (C) 2016 by the American College of Cardiology Foundation. BACKGROUNDStudies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex.OBJECTIVESThis study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR.METHODSIn 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents.RESULTSThe cohort had a mean age of 64 ± 15 years, was 66% male, and had a mean ejection fraction 64 ± 9%, mean regurgitant volume 67 ± 31 ml, and low mean Charlson comorbidity index of 1.09 ± 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23).CONCLUSIONSIn patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. Abstract Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Objectives This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. Methods In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents. Results The cohort had a mean age of 64 ± 15 years, was 66% male, and had a mean ejection fraction 64 ± 9%, mean regurgitant volume 67 ± 31 ml, and low mean Charlson comorbidity index of 1.09 ± 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23). Conclusions In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Objectives This study assessed the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. Methods In 1,331 patients with degenerative MR, BNP was prospectively measured at diagnosis and expressed as BNPratio (ratio to upper limit of normal for age, sex, and assay). Initial surgical management was performed within 3 months of diagnosis in 561 patents. Results The cohort had a mean age of 64 plus or minus 15 years, was 66% male, and had a mean ejection fraction 64 plus or minus 9%, mean regurgitant volume 67 plus or minus 31 ml, and low mean Charlson comorbidity index of 1.09 plus or minus 1.76. Median BNPratio was 1.01 (25th and 75th percentiles: 0.42 to 2.36). Overall, BNPratio was a powerful, independent predictor of mortality (hazard ratio: 1.33 [95% confidence interval: 1.15 to 1.54]; p < 0.0001), whereas absolute BNP was not (p = 0.43). In patients who were initially treated medically (n = 770; 58%), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (hazard ratio: 1.61 [95% confidence interval: 1.34 to 1.93]; p < 0.0001). Higher BNP activation was associated with higher mortality (p < 0.0001). All subgroups, particularly severe MR, incurred similar excess mortality with BNP activation. After initial surgical treatment (n = 561, 42%) BNP activation did not impose excess long-term mortality (p = 0.23). Conclusions In patients with degenerative MR, BNPratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNPratio should be incorporated into the routine clinical assessment of patients with degenerative MR. |
| Author | Enriquez-Sarano, Maurice, MD Szymanski, Catherine, MD Lazam, Siham, MD Oberti, Pablo, MD Suri, Rakesh M., MD, DPhil Pizarro, Rodolfo, MD Vanoverschelde, Jean-Louis, MD Jaffe, Allan, MD Michelena, Hector I., MD Clavel, Marie-Annick, DVM, PhD Tribouilloy, Christophe, MD |
| Author_xml | – sequence: 1 fullname: Clavel, Marie-Annick, DVM, PhD – sequence: 2 fullname: Tribouilloy, Christophe, MD – sequence: 3 fullname: Vanoverschelde, Jean-Louis, MD – sequence: 4 fullname: Pizarro, Rodolfo, MD – sequence: 5 fullname: Suri, Rakesh M., MD, DPhil – sequence: 6 fullname: Szymanski, Catherine, MD – sequence: 7 fullname: Lazam, Siham, MD – sequence: 8 fullname: Oberti, Pablo, MD – sequence: 9 fullname: Michelena, Hector I., MD – sequence: 10 fullname: Jaffe, Allan, MD – sequence: 11 fullname: Enriquez-Sarano, Maurice, MD |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27634121$$D View this record in MEDLINE/PubMed https://u-picardie.hal.science/hal-03580780$$DView record in HAL |
| BookMark | eNqNkt9qFDEUxoNU7Lb6Al7IgDd6MWv-TCYJSGFtqxVWLbbiZchmzmyznZ1Zk8zAvo3P4pOZ2a0VeiHCgYST3_mSk-8coYO2awGh5wRPCSblm9V0Zayd0rSf4hSFeIQmhHOZM67EAZpgwXhOsBKH6CiEFca4lEQ9QYdUlKwglEzQ7SyEzjoTXddmXZ29y6-3G8g-m-hd7yE6m13CJroKfv387uJNdtX7wQ2myVybXaYyaGPIdidnsIQWfMoNkH1y0SfoKyx7v3Rxp_8UPa5NE-DZ3XqMvr0_vz69yOdfPnw8nc1zyzmOeWULXBQLwutaKVWomleUwWIBpi4ZpTVjwGkplFWsMoxJI4QsLQFCeEFKxdkxer3XvTGN3ni3Nn6rO-P0xWyuxxxmXGIh8UAS-2rPbnz3o4cQ9doFC01jWuj6oIkUVBZlqcr_QCnmiSMyoS8foKuu921qekcpogTHiaJ7yvouBA_1_WMJ1qPDeqVHh_XosMYpCpGKXtxJ94s1VPclfyxNwNs9AOmLBwdeB5tcslA5DzbqqnP_1j95UG4b1zprmlvYQvjbhw5UY301ztg4YiRdz2Xq_Tc6Ksx3 |
| CitedBy_id | crossref_primary_10_1016_j_jaccas_2022_08_032 crossref_primary_10_1001_jamacardio_2019_5466 crossref_primary_10_1016_j_cjca_2020_12_011 crossref_primary_10_1093_eurheartj_ehx465 crossref_primary_10_1161_CIR_0000000000000923 crossref_primary_10_1136_heartjnl_2016_310482 crossref_primary_10_1093_eurheartj_ehab395 crossref_primary_10_3389_fcvm_2023_1076708 crossref_primary_10_2217_fca_2020_0189 crossref_primary_10_1007_s11886_019_1163_3 crossref_primary_10_1093_ejcts_ezab389 crossref_primary_10_1186_s44348_024_00021_6 crossref_primary_10_1161_JAHA_121_024814 crossref_primary_10_1161_CIRCULATIONAHA_122_062612 crossref_primary_10_1016_j_jacc_2016_07_717 crossref_primary_10_3390_medicina59122083 crossref_primary_10_1080_14779072_2019_1553619 crossref_primary_10_1016_j_jacc_2022_09_044 crossref_primary_10_1161_CIRCULATIONAHA_118_039066 crossref_primary_10_1016_j_jacc_2020_11_018 crossref_primary_10_1161_CIR_0000000000000932 crossref_primary_10_3389_fcvm_2023_1134828 crossref_primary_10_1007_s00108_024_01676_5 crossref_primary_10_1016_j_jacc_2019_06_032 crossref_primary_10_1016_j_jacc_2020_11_035 crossref_primary_10_1016_j_recesp_2021_11_023 crossref_primary_10_4244_EIJ_E_21_00009 crossref_primary_10_1016_j_jacc_2020_02_031 crossref_primary_10_1016_j_jacc_2020_02_030 crossref_primary_10_1016_j_jtcvs_2021_04_002 crossref_primary_10_1016_j_pcad_2017_10_005 crossref_primary_10_3390_jcm9051348 crossref_primary_10_1016_j_jacc_2017_01_005 crossref_primary_10_1016_j_pcad_2017_11_004 crossref_primary_10_1002_ejhf_2339 crossref_primary_10_1016_j_pcad_2017_11_007 crossref_primary_10_1007_s00392_017_1113_2 |
| Cites_doi | 10.1016/j.jcmg.2007.12.005 10.1016/j.jacc.2014.02.537 10.1136/heartjnl-2011-301128 10.1016/S1760-2734(06)70002-9 10.1111/j.1939-1676.2009.0347.x 10.1161/CIRCULATIONAHA.105.599175 10.1161/CIRCULATIONAHA.113.005287 10.1111/j.1540-8191.2008.00683.x 10.4065/78.4.481 10.1056/NEJMoa041451 10.1016/j.amjcard.2005.10.061 10.1016/S0735-1097(02)02059-4 10.1016/S0735-1097(03)00486-8 10.1161/CIRCULATIONAHA.112.000699 10.1016/j.jtcvs.2014.08.084 10.1373/clinchem.2004.044594 10.1001/jama.2013.8643 10.1016/S0894-7317(03)00335-3 10.1093/eurheartj/eht345 10.1093/eurjhf/hfq189 10.1161/01.CIR.88.3.1004 10.1016/j.athoracsur.2013.06.051 10.1093/eurjhf/hfs114 10.1016/j.amjcard.2009.04.023 10.1016/0021-9681(87)90171-8 10.1016/j.jacc.2014.02.581 10.1016/j.jtcvs.2015.04.009 10.1161/CIRCULATIONAHA.109.884866 10.1016/j.echo.2008.11.029 10.1093/eurheartj/ehs109 10.1161/01.CIR.0000164269.80908.9D 10.1016/j.jacc.2009.06.013 10.1016/S0828-282X(07)70758-4 10.1016/j.jacc.2008.01.041 10.1093/ejcts/ezs513 10.1016/j.jacc.2006.05.021 |
| ContentType | Journal Article |
| Copyright | American College of Cardiology Foundation 2016 American College of Cardiology Foundation Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Sep 20, 2016 Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: American College of Cardiology Foundation – notice: 2016 American College of Cardiology Foundation – notice: Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Sep 20, 2016 – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 1XC |
| DOI | 10.1016/j.jacc.2016.06.047 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Hyper Article en Ligne (HAL) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1558-3597 |
| EndPage | 1307 |
| ExternalDocumentID | oai_HAL_hal_03580780v1 4186874001 10_1016_j_jacc_2016_06_047 27634121 S0735109716345818 1_s2_0_S0735109716345818 |
| Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0SF 18M 1B1 1CY 1P~ 1~. 1~5 29L 2WC 3O- 3V. 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 6PF 7-5 71M 7RV 8P~ AABNK AABVL AACTN AAEDT AAEDW AAFTH AAIKJ AAKUH AALRI AAOAW AAQFI AAQQT AAQXK AAXUO AAYOK ABBQC ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABVKL ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ADBBV ADEZE ADMUD ADVLN AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFETI AFFNX AFRAH AFRHN AFTJW AGHFR AGYEJ AHMBA AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AZFZN BAWUL BENPR BLXMC BPHCQ CS3 DIK DU5 E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU G-Q GBLVA GX1 H13 HVGLF HX~ HZ~ IHE IXB J1W J5H K-O KQ8 L7B MO0 N4W N9A NCXOZ O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 QTD R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SSZ T5K TR2 UNMZH UV1 W8F WH7 WOQ WOW X7M XPP YYM YYP YZZ Z5R ZGI ZXP AAIAV EFLBG LCYCR NAHTW ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 1XC |
| ID | FETCH-LOGICAL-c550t-dc4044b15ff99949f5d23ebbeaf6322f33e52679c93da338a7786c1e115416953 |
| ISSN | 0735-1097 |
| IngestDate | Tue Oct 15 15:24:08 EDT 2024 Fri Oct 25 09:07:43 EDT 2024 Thu Oct 24 23:05:29 EDT 2024 Thu Oct 10 22:47:05 EDT 2024 Thu Sep 12 17:57:07 EDT 2024 Wed Oct 16 00:59:47 EDT 2024 Fri Feb 23 02:33:28 EST 2024 Tue Oct 15 22:56:09 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | degenerative mitral valve regurgitation BNP MR mitral regurgitation degenerative mitral regurgitation survival brain natriuretic peptide DMR LVEF LV left ventricular ejection fraction B-type natriuretic peptide Doppler echocardiography valvular heart disease left ventricle/ventricular |
| Language | English |
| License | This article is made available under the Elsevier license. Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c550t-dc4044b15ff99949f5d23ebbeaf6322f33e52679c93da338a7786c1e115416953 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-7867-3668 0000-0003-1842-8307 0000-0002-8133-8913 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.jacc.2016.06.047 |
| PMID | 27634121 |
| PQID | 1820919750 |
| PQPubID | 2031078 |
| PageCount | 11 |
| ParticipantIDs | hal_primary_oai_HAL_hal_03580780v1 proquest_miscellaneous_1872846696 proquest_miscellaneous_1820596318 proquest_journals_1820919750 crossref_primary_10_1016_j_jacc_2016_06_047 pubmed_primary_27634121 elsevier_sciencedirect_doi_10_1016_j_jacc_2016_06_047 elsevier_clinicalkeyesjournals_1_s2_0_S0735109716345818 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-09-20 |
| PublicationDateYYYYMMDD | 2016-09-20 |
| PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: New York |
| PublicationTitle | Journal of the American College of Cardiology |
| PublicationTitleAlternate | J Am Coll Cardiol |
| PublicationYear | 2016 |
| Publisher | Elsevier Inc Elsevier Limited Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Elsevier |
| References | Magne, Mahjoub, Pibarot (bib21) 2012; 14 Nishimura, Otto, Bonow (bib1) 2014; 63 Klaar, Gabriel, Bergler-Klein (bib8) 2011; 13 Enriquez-Sarano, Avierinos, Messika-Zeitoun (bib27) 2005; 352 Magne, Mahjoub, Pierard (bib9) 2012; 98 Filsoufi, Rahmanian, Salzberg (bib23) 2008; 23 Apple, Panteghini, Ravkilde (bib25) 2005; 51 Naji, Griffin, Asfahan (bib32) 2014; 129 Di Angelantonio, Chowdhury, Sarwar (bib16) 2009; 120 Detaint, Messika-Zeitoun, Chen (bib5) 2006; 97 David, Armstrong, McCrindle, Manlhiot (bib31) 2013; 127 Zoghbi, Enriquez-Sarano, Foster (bib12) 2003; 16 Hwang, Kim, Kim (bib22) 2013; 43 Vassileva, McNeely, Spertus (bib33) 2015; 149 Rosenhek, Rader, Klaar (bib28) 2006; 113 Sutton, Stewart, Gerber (bib3) 2003; 41 Detaint, Messika-Zeitoun, Avierinos (bib4) 2005; 111 Chatterjee, Rankin, Gammie (bib34) 2013; 96 Bonow, Carabello, Chatterjee (bib36) 2006; 48 Enriquez-Sarano, Suri, Clavel (bib2) 2015; 150 Shimamoto, Kusumoto, Sakai (bib6) 2007; 23 Charlson, Pompei, Ales, MacKenzie (bib10) 1987; 40 Wei, Heublein, Perrella (bib13) 1993; 88 Chetboul, Serres, Tissier (bib19) 2009; 23 Vahanian, Alfieri, Andreotti (bib35) 2012; 33 Khan, Dhillon, Kelly (bib15) 2008; 51 Redfield, Rodeheffer, Jacobsen (bib24) 2002; 40 Shapiro, Chen, Burnett, Redfield (bib14) 2003; 78 Potocki, Mair, Weber (bib17) 2009; 104 Grigioni, Tribouilloy, Avierinos (bib30) 2008; 1 Pizarro, Bazzino, Oberti (bib7) 2009; 54 Magne, Mahjoub, Dulgheru (bib20) 2014; 35 Baumgartner, Hung, Bermejo (bib11) 2009; 22 Suri, Vanoverschelde, Grigioni (bib29) 2013; 310 Haggstrom, Hansson, Kvart (bib18) 2000; 2 Clavel, Malouf, Michelena (bib26) 2014; 63 27634122 - J Am Coll Cardiol. 2016 Sep 20;68(12):1308-11 Chetboul (10.1016/j.jacc.2016.06.047_bib19) 2009; 23 Clavel (10.1016/j.jacc.2016.06.047_bib26) 2014; 63 Magne (10.1016/j.jacc.2016.06.047_bib9) 2012; 98 Enriquez-Sarano (10.1016/j.jacc.2016.06.047_bib2) 2015; 150 Bonow (10.1016/j.jacc.2016.06.047_bib36) 2006; 48 Shimamoto (10.1016/j.jacc.2016.06.047_bib6) 2007; 23 Vahanian (10.1016/j.jacc.2016.06.047_bib35) 2012; 33 Apple (10.1016/j.jacc.2016.06.047_bib25) 2005; 51 Di Angelantonio (10.1016/j.jacc.2016.06.047_bib16) 2009; 120 Chatterjee (10.1016/j.jacc.2016.06.047_bib34) 2013; 96 Wei (10.1016/j.jacc.2016.06.047_bib13) 1993; 88 Magne (10.1016/j.jacc.2016.06.047_bib20) 2014; 35 Charlson (10.1016/j.jacc.2016.06.047_bib10) 1987; 40 Nishimura (10.1016/j.jacc.2016.06.047_bib1) 2014; 63 Detaint (10.1016/j.jacc.2016.06.047_bib4) 2005; 111 Pizarro (10.1016/j.jacc.2016.06.047_bib7) 2009; 54 Shapiro (10.1016/j.jacc.2016.06.047_bib14) 2003; 78 David (10.1016/j.jacc.2016.06.047_bib31) 2013; 127 Zoghbi (10.1016/j.jacc.2016.06.047_bib12) 2003; 16 Redfield (10.1016/j.jacc.2016.06.047_bib24) 2002; 40 Vassileva (10.1016/j.jacc.2016.06.047_bib33) 2015; 149 Klaar (10.1016/j.jacc.2016.06.047_bib8) 2011; 13 Filsoufi (10.1016/j.jacc.2016.06.047_bib23) 2008; 23 Khan (10.1016/j.jacc.2016.06.047_bib15) 2008; 51 Potocki (10.1016/j.jacc.2016.06.047_bib17) 2009; 104 Magne (10.1016/j.jacc.2016.06.047_bib21) 2012; 14 Enriquez-Sarano (10.1016/j.jacc.2016.06.047_bib27) 2005; 352 Naji (10.1016/j.jacc.2016.06.047_bib32) 2014; 129 Sutton (10.1016/j.jacc.2016.06.047_bib3) 2003; 41 Suri (10.1016/j.jacc.2016.06.047_bib29) 2013; 310 Haggstrom (10.1016/j.jacc.2016.06.047_bib18) 2000; 2 Rosenhek (10.1016/j.jacc.2016.06.047_bib28) 2006; 113 Detaint (10.1016/j.jacc.2016.06.047_bib5) 2006; 97 Grigioni (10.1016/j.jacc.2016.06.047_bib30) 2008; 1 Baumgartner (10.1016/j.jacc.2016.06.047_bib11) 2009; 22 Hwang (10.1016/j.jacc.2016.06.047_bib22) 2013; 43 |
| References_xml | – volume: 129 start-page: 1310 year: 2014 end-page: 1319 ident: bib32 article-title: Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography publication-title: Circulation contributor: fullname: Asfahan – volume: 96 start-page: 1587 year: 2013 end-page: 1594 ident: bib34 article-title: Isolated mitral valve surgery risk in 77,836 patients from the Society of Thoracic Surgeons database publication-title: Ann Thorac Surg contributor: fullname: Gammie – volume: 13 start-page: 163 year: 2011 end-page: 169 ident: bib8 article-title: Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation publication-title: Eur J Heart Fail contributor: fullname: Bergler-Klein – volume: 40 start-page: 976 year: 2002 end-page: 982 ident: bib24 article-title: Plasma brain natriuretic peptide concentration: impact of age and gender publication-title: J Am Coll Cardiol contributor: fullname: Jacobsen – volume: 51 start-page: 486 year: 2005 end-page: 493 ident: bib25 article-title: Quality specifications for B-type natriuretic peptide assays publication-title: Clin Chem contributor: fullname: Ravkilde – volume: 2 start-page: 7 year: 2000 end-page: 16 ident: bib18 article-title: Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease publication-title: Journal Vet Cardiol contributor: fullname: Kvart – volume: 97 start-page: 1029 year: 2006 end-page: 1034 ident: bib5 article-title: Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation publication-title: Am J Cardiol contributor: fullname: Chen – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: bib10 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis contributor: fullname: MacKenzie – volume: 22 start-page: 1 year: 2009 end-page: 23 ident: bib11 article-title: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice publication-title: J Am Soc Echocardiogr contributor: fullname: Bermejo – volume: 14 start-page: 1293 year: 2012 end-page: 1302 ident: bib21 article-title: Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation publication-title: Eur J Heart Fail contributor: fullname: Pibarot – volume: 150 start-page: 50 year: 2015 end-page: 58 ident: bib2 article-title: Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation publication-title: J Thorac Cardiovasc Surg contributor: fullname: Clavel – volume: 33 start-page: 2451 year: 2012 end-page: 2496 ident: bib35 article-title: Guidelines on the management of valvular heart disease (version 2012) publication-title: Eur Heart J contributor: fullname: Andreotti – volume: 104 start-page: 559 year: 2009 end-page: 564 ident: bib17 article-title: Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation publication-title: Am J Cardiol contributor: fullname: Weber – volume: 149 start-page: 762 year: 2015 end-page: 768.e1 ident: bib33 article-title: Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients publication-title: J Thorac Cardiovasc Surg contributor: fullname: Spertus – volume: 98 start-page: 584 year: 2012 end-page: 591 ident: bib9 article-title: Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation publication-title: Heart contributor: fullname: Pierard – volume: 63 start-page: 2016 year: 2014 end-page: 2025 ident: bib26 article-title: B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival publication-title: J Am Coll Cardiol contributor: fullname: Michelena – volume: 310 start-page: 609 year: 2013 end-page: 616 ident: bib29 article-title: Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets publication-title: JAMA contributor: fullname: Grigioni – volume: 23 start-page: 984 year: 2009 end-page: 994 ident: bib19 article-title: Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease publication-title: J Veterinary Intern Med contributor: fullname: Tissier – volume: 23 start-page: 600 year: 2008 end-page: 605 ident: bib23 article-title: B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery publication-title: J Card Surg contributor: fullname: Salzberg – volume: 120 start-page: 2177 year: 2009 end-page: 2187 ident: bib16 article-title: B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies publication-title: Circulation contributor: fullname: Sarwar – volume: 41 start-page: 2280 year: 2003 end-page: 2287 ident: bib3 article-title: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation publication-title: J Am Coll Cardiol contributor: fullname: Gerber – volume: 35 start-page: 1608 year: 2014 end-page: 1616 ident: bib20 article-title: Left ventricular contractile reserve in asymptomatic primary mitral regurgitation publication-title: Eur Heart J contributor: fullname: Dulgheru – volume: 16 start-page: 777 year: 2003 end-page: 802 ident: bib12 article-title: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography publication-title: J Am Soc Echocardiogr contributor: fullname: Foster – volume: 43 start-page: e1 year: 2013 end-page: e6 ident: bib22 article-title: Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results publication-title: Eur J Cardiothorac Surg contributor: fullname: Kim – volume: 78 start-page: 481 year: 2003 end-page: 486 ident: bib14 article-title: Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure publication-title: Mayo Clin Proc contributor: fullname: Redfield – volume: 54 start-page: 1099 year: 2009 end-page: 1106 ident: bib7 article-title: Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation publication-title: J Am Coll Cardiol contributor: fullname: Oberti – volume: 63 start-page: 2438 year: 2014 end-page: 2488 ident: bib1 article-title: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: J Am Coll Cardiol contributor: fullname: Bonow – volume: 88 start-page: 1004 year: 1993 end-page: 1009 ident: bib13 article-title: Natriuretic peptide system in human heart failure publication-title: Circulation contributor: fullname: Perrella – volume: 51 start-page: 1857 year: 2008 end-page: 1864 ident: bib15 article-title: Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study publication-title: J Am Coll Cardiol contributor: fullname: Kelly – volume: 352 start-page: 875 year: 2005 end-page: 883 ident: bib27 article-title: Quantitative determinants of the outcome of asymptomatic mitral regurgitation publication-title: N Engl J Med contributor: fullname: Messika-Zeitoun – volume: 113 start-page: 2238 year: 2006 end-page: 2244 ident: bib28 article-title: Outcome of watchful waiting in asymptomatic severe mitral regurgitation publication-title: Circulation contributor: fullname: Klaar – volume: 127 start-page: 1485 year: 2013 end-page: 1492 ident: bib31 article-title: Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease publication-title: Circulation contributor: fullname: Manlhiot – volume: 111 start-page: 2391 year: 2005 end-page: 2397 ident: bib4 article-title: B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome publication-title: Circulation contributor: fullname: Avierinos – volume: 48 start-page: e1 year: 2006 end-page: e148 ident: bib36 article-title: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons publication-title: J Am Coll Cardiol contributor: fullname: Chatterjee – volume: 1 start-page: 133 year: 2008 end-page: 141 ident: bib30 article-title: Outcomes in mitral regurgitation due to flail leaflets a multicenter European study publication-title: J Am Coll Cardiol Img contributor: fullname: Avierinos – volume: 23 start-page: 295 year: 2007 end-page: 300 ident: bib6 article-title: Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation publication-title: Can J Cardiol contributor: fullname: Sakai – volume: 1 start-page: 133 year: 2008 ident: 10.1016/j.jacc.2016.06.047_bib30 article-title: Outcomes in mitral regurgitation due to flail leaflets a multicenter European study publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2007.12.005 contributor: fullname: Grigioni – volume: 63 start-page: 2438 year: 2014 ident: 10.1016/j.jacc.2016.06.047_bib1 article-title: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.02.537 contributor: fullname: Nishimura – volume: 98 start-page: 584 year: 2012 ident: 10.1016/j.jacc.2016.06.047_bib9 article-title: Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation publication-title: Heart doi: 10.1136/heartjnl-2011-301128 contributor: fullname: Magne – volume: 2 start-page: 7 year: 2000 ident: 10.1016/j.jacc.2016.06.047_bib18 article-title: Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease publication-title: Journal Vet Cardiol doi: 10.1016/S1760-2734(06)70002-9 contributor: fullname: Haggstrom – volume: 23 start-page: 984 year: 2009 ident: 10.1016/j.jacc.2016.06.047_bib19 article-title: Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease publication-title: J Veterinary Intern Med doi: 10.1111/j.1939-1676.2009.0347.x contributor: fullname: Chetboul – volume: 113 start-page: 2238 year: 2006 ident: 10.1016/j.jacc.2016.06.047_bib28 article-title: Outcome of watchful waiting in asymptomatic severe mitral regurgitation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.599175 contributor: fullname: Rosenhek – volume: 129 start-page: 1310 year: 2014 ident: 10.1016/j.jacc.2016.06.047_bib32 article-title: Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005287 contributor: fullname: Naji – volume: 23 start-page: 600 year: 2008 ident: 10.1016/j.jacc.2016.06.047_bib23 article-title: B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery publication-title: J Card Surg doi: 10.1111/j.1540-8191.2008.00683.x contributor: fullname: Filsoufi – volume: 78 start-page: 481 year: 2003 ident: 10.1016/j.jacc.2016.06.047_bib14 article-title: Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure publication-title: Mayo Clin Proc doi: 10.4065/78.4.481 contributor: fullname: Shapiro – volume: 352 start-page: 875 year: 2005 ident: 10.1016/j.jacc.2016.06.047_bib27 article-title: Quantitative determinants of the outcome of asymptomatic mitral regurgitation publication-title: N Engl J Med doi: 10.1056/NEJMoa041451 contributor: fullname: Enriquez-Sarano – volume: 97 start-page: 1029 year: 2006 ident: 10.1016/j.jacc.2016.06.047_bib5 article-title: Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.10.061 contributor: fullname: Detaint – volume: 40 start-page: 976 year: 2002 ident: 10.1016/j.jacc.2016.06.047_bib24 article-title: Plasma brain natriuretic peptide concentration: impact of age and gender publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)02059-4 contributor: fullname: Redfield – volume: 41 start-page: 2280 year: 2003 ident: 10.1016/j.jacc.2016.06.047_bib3 article-title: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00486-8 contributor: fullname: Sutton – volume: 127 start-page: 1485 year: 2013 ident: 10.1016/j.jacc.2016.06.047_bib31 article-title: Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.000699 contributor: fullname: David – volume: 149 start-page: 762 year: 2015 ident: 10.1016/j.jacc.2016.06.047_bib33 article-title: Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2014.08.084 contributor: fullname: Vassileva – volume: 51 start-page: 486 year: 2005 ident: 10.1016/j.jacc.2016.06.047_bib25 article-title: Quality specifications for B-type natriuretic peptide assays publication-title: Clin Chem doi: 10.1373/clinchem.2004.044594 contributor: fullname: Apple – volume: 310 start-page: 609 year: 2013 ident: 10.1016/j.jacc.2016.06.047_bib29 article-title: Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets publication-title: JAMA doi: 10.1001/jama.2013.8643 contributor: fullname: Suri – volume: 16 start-page: 777 year: 2003 ident: 10.1016/j.jacc.2016.06.047_bib12 article-title: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography publication-title: J Am Soc Echocardiogr doi: 10.1016/S0894-7317(03)00335-3 contributor: fullname: Zoghbi – volume: 35 start-page: 1608 year: 2014 ident: 10.1016/j.jacc.2016.06.047_bib20 article-title: Left ventricular contractile reserve in asymptomatic primary mitral regurgitation publication-title: Eur Heart J doi: 10.1093/eurheartj/eht345 contributor: fullname: Magne – volume: 13 start-page: 163 year: 2011 ident: 10.1016/j.jacc.2016.06.047_bib8 article-title: Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfq189 contributor: fullname: Klaar – volume: 88 start-page: 1004 year: 1993 ident: 10.1016/j.jacc.2016.06.047_bib13 article-title: Natriuretic peptide system in human heart failure publication-title: Circulation doi: 10.1161/01.CIR.88.3.1004 contributor: fullname: Wei – volume: 96 start-page: 1587 year: 2013 ident: 10.1016/j.jacc.2016.06.047_bib34 article-title: Isolated mitral valve surgery risk in 77,836 patients from the Society of Thoracic Surgeons database publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2013.06.051 contributor: fullname: Chatterjee – volume: 14 start-page: 1293 year: 2012 ident: 10.1016/j.jacc.2016.06.047_bib21 article-title: Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfs114 contributor: fullname: Magne – volume: 104 start-page: 559 year: 2009 ident: 10.1016/j.jacc.2016.06.047_bib17 article-title: Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2009.04.023 contributor: fullname: Potocki – volume: 40 start-page: 373 year: 1987 ident: 10.1016/j.jacc.2016.06.047_bib10 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 contributor: fullname: Charlson – volume: 63 start-page: 2016 year: 2014 ident: 10.1016/j.jacc.2016.06.047_bib26 article-title: B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.02.581 contributor: fullname: Clavel – volume: 150 start-page: 50 year: 2015 ident: 10.1016/j.jacc.2016.06.047_bib2 article-title: Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2015.04.009 contributor: fullname: Enriquez-Sarano – volume: 120 start-page: 2177 year: 2009 ident: 10.1016/j.jacc.2016.06.047_bib16 article-title: B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.884866 contributor: fullname: Di Angelantonio – volume: 22 start-page: 1 year: 2009 ident: 10.1016/j.jacc.2016.06.047_bib11 article-title: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2008.11.029 contributor: fullname: Baumgartner – volume: 33 start-page: 2451 year: 2012 ident: 10.1016/j.jacc.2016.06.047_bib35 article-title: Guidelines on the management of valvular heart disease (version 2012) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs109 contributor: fullname: Vahanian – volume: 111 start-page: 2391 year: 2005 ident: 10.1016/j.jacc.2016.06.047_bib4 article-title: B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome publication-title: Circulation doi: 10.1161/01.CIR.0000164269.80908.9D contributor: fullname: Detaint – volume: 54 start-page: 1099 year: 2009 ident: 10.1016/j.jacc.2016.06.047_bib7 article-title: Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.06.013 contributor: fullname: Pizarro – volume: 23 start-page: 295 year: 2007 ident: 10.1016/j.jacc.2016.06.047_bib6 article-title: Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation publication-title: Can J Cardiol doi: 10.1016/S0828-282X(07)70758-4 contributor: fullname: Shimamoto – volume: 51 start-page: 1857 year: 2008 ident: 10.1016/j.jacc.2016.06.047_bib15 article-title: Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.01.041 contributor: fullname: Khan – volume: 43 start-page: e1 year: 2013 ident: 10.1016/j.jacc.2016.06.047_bib22 article-title: Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezs513 contributor: fullname: Hwang – volume: 48 start-page: e1 year: 2006 ident: 10.1016/j.jacc.2016.06.047_bib36 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.05.021 contributor: fullname: Bonow |
| SSID | ssj0006819 |
| Score | 2.43557 |
| Snippet | Abstract Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size,... Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies,... Background Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent... BACKGROUNDStudies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent... BACKGROUND Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent... |
| SourceID | hal proquest crossref pubmed elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 1297 |
| SubjectTerms | Aged brain natriuretic peptide Cardiac arrhythmia Cardiology Cardiovascular Cardiovascular disease Clinical medicine Comorbidity degenerative mitral regurgitation Doppler echocardiography Dyspnea Female Heart failure Hospitals Humans Hypertension Internal Medicine Laboratories Life Sciences Male Medical referrals Middle Aged Mitral Valve Insufficiency - blood Mitral Valve Insufficiency - mortality Mitral Valve Insufficiency - surgery Mortality Natriuretic Peptide, Brain - blood Patients Peptides Prospective Studies Pulmonary arteries Studies Surgery survival Survival Rate valvular heart disease |
| Title | Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0735109716345818 https://dx.doi.org/10.1016/j.jacc.2016.06.047 https://www.ncbi.nlm.nih.gov/pubmed/27634121 https://www.proquest.com/docview/1820919750 https://search.proquest.com/docview/1820596318 https://search.proquest.com/docview/1872846696 https://u-picardie.hal.science/hal-03580780 |
| Volume | 68 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbaISFeEPcFBjKIPU2Z4tzzWLqiCq1oouMiXqwkdkpKlaB26QO_ht_CL-McO7cxigCJl6hyksbx-eJzfPz5MyHPHRT1ti1hpsIWJk6cmYkTW2bsZilzRGLLBGd0p_Pg9YfwZOJOBoNmV9au7L9aGsrA1rhy9i-s3f4pFMBvsDkcwepw_CO799obA8EXJo40kZO8ziu1YvHoDIksQh6O7cOR9R7zsPMKOoytkt9Azf5crXpTZ07kQulSK4LRLMe0CFhkUa0XeW8O_2pw21uwUvSTE2NFf-1n8sereKuZAjMctpujomiE-jGhsM6TsspXK50y7KQQmgvexQWSUDdIaNUKwq9kXJincFM7WjjLv6LUpCaSi3KVlf1cB_ORmGFbXQKuWYRziSMKnRSKqWqa77Gs-3EvNB2vLqs7ej_sA9ruddsQ9AS9EAD8evBL96IzHcvjZZyi_CXzlfarG3TOtKU4zrFaTCl0Oa4HYdGQXLOhM8T9HT56b9powQ_V5jPtS9QLuzQH8efn7Aqehp-QxbtriKRCpfNb5GYNAzrS4LxNBrK4Q67PahbHXfK5h1FaZlRjlPYwSmuMfv-GKKQNPmle0AafVJ3p45NqfNJL-LxH3r6cnI-nZr3ph5nCYPnCFKlruW7CvCyDsYsbZZ6wHZkkMs58cD6Z40jP9oMojRwRO04YowBiyiTKSjE_8pz7ZK8oC7lPqEjg3tRKWOrHrh9lSZSEgYhkKjwRWXFikKOmNfkXre3CG9LjkmPbc2x7jsxPNzBI0DQ4b1Ytg5-Vm_rj33DGNza3-BXLG8Rr76zjWh2vcsDVb5_4DOzaVg2F4KejU45lFrIXgtDaMoMcNGbnXU0gro9YBKMBgzxtT4PjwNnAuJBlpa_xwP1i_XZfE0D46vuRb5AHGlJtdWyITFxms4f_-HaPyI3uEz8gexfrSj4mw42onqgv5AcyL_6P |
| link.rule.ids | 230,315,782,786,887,27934,27935 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+B-Type+Natriuretic+Peptide%C2%A0With+Survival+in+Patients+With+Degenerative+Mitral+Regurgitation&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Clavel%2C+Marie-Annick&rft.au=Tribouilloy%2C+Christophe&rft.au=Vanoverschelde%2C+Jean-Louis&rft.au=Pizarro%2C+Rodolfo&rft.date=2016-09-20&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=68&rft.issue=12&rft.spage=1297&rft.epage=1307&rft_id=info:doi/10.1016%2Fj.jacc.2016.06.047&rft.externalDocID=S0735109716345818 |
| thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109716X00320%2Fcov150h.gif |